UY28777A1 - Bloqueadores de kv 1.5 para aumentar selectivamente la contractilidad auricular y tratar la insuficiencia cardíaca - Google Patents

Bloqueadores de kv 1.5 para aumentar selectivamente la contractilidad auricular y tratar la insuficiencia cardíaca

Info

Publication number
UY28777A1
UY28777A1 UY28777A UY28777A UY28777A1 UY 28777 A1 UY28777 A1 UY 28777A1 UY 28777 A UY28777 A UY 28777A UY 28777 A UY28777 A UY 28777A UY 28777 A1 UY28777 A1 UY 28777A1
Authority
UY
Uruguay
Prior art keywords
heart failure
blockers
contractility
headphone
selectively increase
Prior art date
Application number
UY28777A
Other languages
English (en)
Inventor
Dr Klaus Wirth
Original Assignee
Sanofi Aventis Deutschland
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanofi Aventis Deutschland filed Critical Sanofi Aventis Deutschland
Publication of UY28777A1 publication Critical patent/UY28777A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4406—Non condensed pyridines; Hydrogenated derivatives thereof only substituted in position 3, e.g. zimeldine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A61K31/166—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide having the carbon of a carboxamide group directly attached to the aromatic ring, e.g. procainamide, procarbazine, metoclopramide, labetalol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/06—Antiarrhythmics

Landscapes

  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Cardiology (AREA)
  • Engineering & Computer Science (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Hospice & Palliative Care (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

La invención se refiere al efecto de los bloqueadores de Kv1.5 para aumentar la contractilidad auricular, especialmente fenilcarboxamidas de las fórmulas la y/o Ib y o sus ssales farmacéuticamente aceptables, para tratar la contractilidad auricular reducida y la insuficiencia cardíaca, especialmente la insuficiencia cardíaca provocada por la disfunción diastólica.
UY28777A 2004-02-26 2005-02-25 Bloqueadores de kv 1.5 para aumentar selectivamente la contractilidad auricular y tratar la insuficiencia cardíaca UY28777A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE102004009931A DE102004009931A1 (de) 2004-02-26 2004-02-26 Kv1.5-Blocker zur selektiven Steigerung der Vorhofkontraktilität und Behandlung der Herzinsuffizienz

Publications (1)

Publication Number Publication Date
UY28777A1 true UY28777A1 (es) 2005-09-30

Family

ID=34853866

Family Applications (1)

Application Number Title Priority Date Filing Date
UY28777A UY28777A1 (es) 2004-02-26 2005-02-25 Bloqueadores de kv 1.5 para aumentar selectivamente la contractilidad auricular y tratar la insuficiencia cardíaca

Country Status (15)

Country Link
US (1) US20070043091A1 (es)
EP (1) EP1720549A1 (es)
JP (1) JP2007523926A (es)
KR (1) KR20060125862A (es)
CN (1) CN1921855A (es)
AR (1) AR047975A1 (es)
AU (1) AU2005218731A1 (es)
BR (1) BRPI0508054A (es)
CA (1) CA2557263A1 (es)
DE (1) DE102004009931A1 (es)
IL (1) IL177255A0 (es)
PE (1) PE20051138A1 (es)
TW (1) TW200536522A (es)
UY (1) UY28777A1 (es)
WO (1) WO2005084675A1 (es)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20090148430A1 (en) * 2004-11-22 2009-06-11 Anne Philippi Human obesity susceptibilty gene encoding potassium ion channels and uses thereof
CN101636154B (zh) * 2006-04-27 2011-12-14 塞诺菲-安万特德国有限公司 Task-1和task-3离子通道抑制剂
CA2761639C (en) * 2009-05-29 2016-06-07 Raqualia Pharma Inc. Aryl substituted carboxamide derivatives as calcium or sodium channel blockers
WO2010139585A2 (en) * 2009-06-03 2010-12-09 Sanofi-Aventis Deutschland Gmbh Crystalline phases of 2'-{[2-(4-methoxy-phenyl)-acetylamino]-methyl}-biphenyl-2-carboxylic acid (2-pyridin-3-yl-ethyl)-amide
CN107033064B (zh) * 2017-04-28 2019-07-09 西安医学院 一种3-(吗啉取代芳亚胺基)吲哚类化合物及其制备方法和应用

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HUT74450A (en) * 1993-12-27 1996-12-30 Eisai Co Ltd Anthranilic acid derivative and pharmaceutical compns. contg. such compds.
US5935945A (en) * 1996-10-31 1999-08-10 Merck & Co., Inc. Methods of treating or preventing cardiac arrhythmia
BR9911914B1 (pt) * 1998-07-08 2010-10-19 n-arilamidas do ácido sulfonilaminocarboxìlico substituìdas por enxofre, processo para sua preparação, bem como preparações farmacêuticas que compreendem as mesmas.
DE19947457A1 (de) * 1999-10-02 2001-04-05 Aventis Pharma Gmbh 2'-Substituierte 1,1'-Biphenyl-2-carbonamide, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament sowie enthaltende pharmazeutische Zubereitungen
US6531495B1 (en) * 1999-10-02 2003-03-11 Aventis Pharma Deutschland Gmbh 2′-Substituted 1,1′-biphenyl-2-carboxamides, processes for their preparation, their use as medicaments, and pharmaceutical preparations comprising them
DE10060809A1 (de) * 2000-12-07 2002-06-20 Aventis Pharma Gmbh Substituierte Anthranilsäuren, ihre Verwendung als Medikament oder Diagnostikum, sowie sie enthaltendes Medikament, sowie ein pharmazeutisches Kombinationspräparat mit einem Natrium/Wasserstoff-Austausch (NHE)-Blocker
DE10121003A1 (de) * 2001-04-28 2002-12-19 Aventis Pharma Gmbh Anthranilsäureamide, Verfahren zur Herstellung, ihrer Verwendung als Medikament sowie sie enthaltende pharmazeutische Zubereitungen
DE10121002A1 (de) * 2001-04-28 2002-11-14 Aventis Pharma Gmbh Verwendung von Anthranilsäureamiden als Medikament zur Behandlung von Arrhythmien sowie sie enthaltende pharmazeutische Zubereitungen
DE10128331A1 (de) * 2001-06-12 2002-12-19 Aventis Pharma Gmbh Anthranilsäureamide mit Heteroarylsulfonyl-Seitenkette, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament oder Diagnostikum sowie sie enthaltende pharmazeutische Zubereitungen
DE10312073A1 (de) * 2003-03-18 2004-09-30 Aventis Pharma Deutschland Gmbh 2-(Butyl-1-sulfonylamino)-N-[1(R)-(6-methoxy-pyridin-3yl)-propyl]-benzamid, dessen Verwendung als Medikament sowie dieses enthaltende pharmazeutische Zubereitungen

Also Published As

Publication number Publication date
CA2557263A1 (en) 2005-09-15
JP2007523926A (ja) 2007-08-23
IL177255A0 (en) 2006-12-10
CN1921855A (zh) 2007-02-28
AU2005218731A1 (en) 2005-09-15
DE102004009931A1 (de) 2005-09-15
EP1720549A1 (de) 2006-11-15
PE20051138A1 (es) 2006-02-06
AR047975A1 (es) 2006-03-15
TW200536522A (en) 2005-11-16
US20070043091A1 (en) 2007-02-22
BRPI0508054A (pt) 2007-07-17
WO2005084675A1 (de) 2005-09-15
KR20060125862A (ko) 2006-12-06

Similar Documents

Publication Publication Date Title
DOP2006000252A (es) Profarmacos mutuos de glucosamina y glucosamina/anti-inflamatorio, composiciones, y metodos
NO20082793L (no) Nye tiofenderivater
DK1543011T3 (da) Thienopyrrolyl- og furanopyrrolylforbindelser og deres anvendelse som histamin H4-receptorligander
NO20091395L (no) Nye tiofenderivater
NO20075298L (no) Novel thiophene derivatives as sphingosine-1-phosphate-1 receptor agonists
NO20062020L (no) 1-amino-2-oksysubstituerte tetrahydronaftalenderivater, fremgangsmate for fremstilling derav, og deres anvendelse som antiflogistika
NO20074959L (no) Substituerte pyridinderivater
DK1458360T3 (da) Pulmonær afgivelse af aminoglycosider
NO20062426L (no) Benzimidazoler nyttige som modulatorer av ionekanaler
NO20083726L (no) Spiroindolinon derivater
NO20014986D0 (no) 4,5-diaryl-3(2H)-furanonderivater som cyklooksygenase-2- inhibitorer
ATE510822T1 (de) Kaliumkanalinhibitoren
EA200501928A1 (ru) Пирролодигидроизохинолины как ингибиторы pde10
TW200744567A (en) Phenylethylamine analogs and their use for treating glaucoma
ATE477805T1 (de) 9a-carbamoyl-y-aminopropyl- und 9a-thiocarbamoyl- y-aminopropyl-azalide mit antimalaria-aktivität
UY28777A1 (es) Bloqueadores de kv 1.5 para aumentar selectivamente la contractilidad auricular y tratar la insuficiencia cardíaca
DK1097173T3 (da) Anvendelse af peptider af IL-2 og derivater deraf som terapeutiske midler
DK1643984T3 (da) Anvendelse af parthenolidderivater som antileukæmiske og cytotoksske midler
DK1578740T3 (da) 1,2,4-triaminobenzenderivater, der er egnede til behandling af lidelser i centralnervesystemet
NO20043952L (no) Benzofuran- og benzotiofenderivater som er nyttige ved behandling av hyperproliferative forstyrrelser
ATE476419T1 (de) Isochinolinon-kaliumkanalinhibitoren
BRPI0511125A (pt) usos de ácido 5,6,7-triidroxieptanóico seus e análogos
PL377441A1 (pl) Sposób wytwarzania stereoizomeru glikopironiowego o konfiguracji R,R (lub S,S)
EA200602081A1 (ru) Пиридиновые производные алкилоксиндолов в качестве агентов, активных в отношении рецептора 5-нт7
DK1492796T3 (da) Substituerede aminoisoxazolinderivater og deres anvendelse som antidepressive midler

Legal Events

Date Code Title Description
DESI Application deemed to be withdrawn

Effective date: 20120418